Suppr超能文献

三种不同遗传背景的三重 MOP、DOP 和 KOP 阿片受体敲除小鼠中,基因型对 D1、D2 受体和多巴胺转运体结合无影响。

Lack of genotype effect on D1, D2 receptors and dopamine transporter binding in triple MOP-, DOP-, and KOP-opioid receptor knockout mice of three different genetic backgrounds.

机构信息

Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.

出版信息

Synapse. 2010 Jul;64(7):520-7. doi: 10.1002/syn.20757.

Abstract

We investigated D1, D2 receptors and dopamine transporter (DAT) binding levels in mice lacking all three opioid receptors and wild-type (WT) mice on three different genetic backgrounds. Quantitative autoradiography was used to determine the level of radioligand binding to the D1 and D2 receptors and DAT labeled with [(3)H]SCH23390, [(3)H]raclopride, and [(3)H]mazindol, respectively in triple-opioid receptor knockout (KO) and WT maintained on C57BL/6 (B6) and 129/SvEvTac (129) as well as C57BL/6 x 129/SvPas (B6 x 129) strains. No significant genotype effect was observed in D1, D2 receptors and DAT binding in any regions analyzed in any of the strains studied, suggesting that a lack of all three opioid receptors does not influence D1, D2 receptors and DAT expression, irrespective of their genetic strain background. However, strain differences were observed in D1 binding between the three strains of mice studied. Lower levels of D1 binding were observed in the substantia nigra of B6 x 129 WT mice compared with the 129 WT mice and in the olfactory tubercle of B6 x 129 WT compared with B6 WT and 129 WT mice. Lower levels of D1 binding were observed in the caudate putamen of B6 x 129 KO mice compared with 129 KO mice. In contrast, no significant strain differences were observed in D2 and DAT binding between the three strains of mice in any regions analyzed. Overall, these results indicate a lack of modulation of the dopaminergic system by the deletion of all three opioid receptors regardless of different background strains.

摘要

我们研究了缺乏三种阿片受体的小鼠和三种不同遗传背景的野生型(WT)小鼠中 D1、D2 受体和多巴胺转运体(DAT)结合水平。使用定量放射自显影术来确定分别用 [(3)H]SCH23390、[(3)H]raclopride 和 [(3)H]mazindol 标记的 D1 和 D2 受体和 DAT 的放射性配体结合水平,在三种阿片受体敲除(KO)和 WT 小鼠中,WT 小鼠维持在 C57BL/6(B6)和 129/SvEvTac(129)以及 C57BL/6 x 129/SvPas(B6 x 129)品系上。在任何研究的品系中,在分析的任何区域均未观察到基因型效应对 D1、D2 受体和 DAT 结合的显著影响,这表明缺乏三种阿片受体不会影响 D1、D2 受体和 DAT 的表达,而与遗传品系背景无关。然而,在三种研究的小鼠品系之间观察到 D1 结合的品系差异。与 129 WT 小鼠相比,B6 x 129 WT 小鼠的黑质中 D1 结合水平较低,与 B6 WT 和 129 WT 小鼠相比,B6 x 129 WT 小鼠的嗅结节中 D1 结合水平较低。与 129 KO 小鼠相比,B6 x 129 KO 小鼠的尾壳核中 D1 结合水平较低。相比之下,在分析的任何区域中,在三种小鼠品系之间均未观察到 D2 和 DAT 结合的显著品系差异。总的来说,这些结果表明,无论不同的背景品系如何,删除三种阿片受体都不会对多巴胺系统产生调节作用。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验